Flecainide: safety and efficacy.
Somberg
John C
JC
D000889:Anti-Arrhythmia Agents / Q000008:administration & dosage* / Q000009:adverse effects*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D064420:Drug-Related Side Effects and Adverse Reactions; D005260:Female; D005424:Flecainide / Q000008:administration & dosage* / Q000009:adverse effects*; D006352:Heart Ventricles / Q000187:drug effects; D006801:Humans; D007668:Kidney / Q000187:drug effects; D008297:Male; D008991:Monitoring, Physiologic / Q000379:methods; D018570:Risk Assessment; D012680:Sensitivity and Specificity; D016896:Treatment Outcome
D000889:Anti-Arrhythmia Agents; D005424:Flecainide